Dr. Ware will present an address entitled “From Populations to Patients: Progress, Challenges and Solutions for Better Understanding Health Outcomes” in the opening plenary of the 23rd Annual ISOQOL Conference. He will provide his perspectives on advances made in the health-related quality of life (HRQOL) measurement field over the past few decades, the major challenges in the field today, and potential conceptual, methodological and technical solutions for these challenges. Dr. Ware also will participate in a session in which he and other senior researchers will give advice to new researchers on successful strategies for dealing with challenges in their research and career paths. In addition, he will take part in a roundtable discussion on the pros and cons of disease-specific and generic HRQOL measures.
JWRG’s Director of Research, Barbara Gandek, also will give a presentation entitled “Can the Accuracy of Generic Health Outcome Predictions Be Improved Using Individualized Disease-Specific QOL Impact Scales?” at the conference. This presentation will compare the accuracy of alternative approaches to measuring total disease impact among heterogeneous populations with multiple chronic conditions. Advances in this area are particularly important for improving case-mix adjustment when generic HRQOL measures are used in observational studies.
More information about the ISOQOL conference can be found here.
John Ware Research Group (JWRG) is a privately held company founded in 2009 by John E. Ware, Jr., PhD to continue innovative research to improve patient-reported outcome (PRO) tools for use in population health surveys, clinical research and clinical practice worldwide.
Phone: +1 (508) 363-1236
10 Wheeler Court, Watertown, MA 02472